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Origins of human cancer
The origins of human cancers have environmental and 
hereditary  components.  Germline  mutations  of  tumor 
suppressor  genes  found  in  cancer  predisposition  syn­
dromes  are  prominent  examples  of  inheritance  and 
include well known tumor suppressor genes, such as the 
retinoblastoma gene (RB), TP53, the breast cancer genes 
BRCA1 and BRCA2, the adenomatous polyposis coli gene 
APC, the mismatch repair genes MLH1 and MSH2 and a 
few others. Although mutations in these genes are very 
rare in the general population, they confer a high risk for 
developing the disease. Mutations in this group of genes 
account  for  only  a  small  fraction  of  the  excess  cancer 
incidence in familial cancer. For some common cancers 
with significant aspects of heritability, such as prostate 
cancer,  highly  penetrant  susceptibility  genes  are  still 
unknown. For these reasons, attention has now shifted 
towards ascribing much of the observed familial cancer 
risk  to  polygenic  models  of  predisposition  in  which 
variant  alleles,  each  conferring  a  small  added  risk, 
cooperate to produce a significant risk factor if several of 
the adverse alleles are inherited. Many of the high­ and 
moderate­risk  genetic  mutations  conferring  enhanced 
cancer  susceptibility  in  families  occur  in  DNA  repair 
genes,  or  DNA  damage  response  genes  in  general, 
suggest  ing that some form of DNA damage or replication 
abnormality is often at the root of cancer initiation.
Recently,  genome­wide  association  studies  (GWASs) 
have provided large datasets for the identification of low­
penetrance  genes  responsible  for  enhanced  cancer 
susceptibility  in  the  general  population.  Most  of  the 
major  cancers  have  now  been  investigated  by  GWASs 
and close to 100 new cancer­susceptibility loci have been 
identified  [1].  For  some  cancers  with  strong  environ­
mental  components,  such  as  lung  cancer,  only  a  few 
signi  ficant loci were found as a result of the overwhelming 
effect  of  cigarette  smoking  on  cancer  risk,  but  other 
cancer types (such as prostate cancer) have yielded many 
(over 20) such loci. Although GWASs are now capturing 
the  excitement  of  the  cancer  genetics  community  and 
numerous  high­profile  studies  with  large  sample  sizes 
and  ever­increasing  genome  coverage  are  being 
published, it should not be forgotten that the majority of 
the cancer risk is thought to be non­genetic (the risk is 
due to the environment) and this is true for the major 
human cancers, including prostate cancer, breast cancer 
and colorectal cancer, for which the heritability accounts 
for  42%,  27%  and  35%  of  the  phenotypic  variance, 
respectively [2]. Thus, in most common cancers, environ­
mental factors supersede the role of genetic inheritance.
Unfortunately,  environmental  components  have 
convincingly been linked to human cancer in only a few 
select  cases.  Most  notable  are  skin  cancers  associated 
with sunlight exposure and lung cancer associated with 
cigarette smoking. Over many decades, epidemiological 
and  molecular  studies  have  established  and  confirmed 
this link. Non­melanoma skin cancer is found on sun­
exposed  skin,  and  melanoma  has  been  linked  with 
intermittent or recreational sun exposure, in particular in 
early childhood [3]. Although the ultraviolet B (UVB, 290 
to  320  nm)  component  of  sunlight  has  generally  been 
implicated  in  these  cancers,  a  role  of  UVA  (320  to 
400 nm) cannot currently be excluded.
Abstract
The etiology of most human cancers is unknown. 
Genetic inheritance and environmental factors are 
thought to have major roles, and for some types of 
cancer, exposure to carcinogens is a proven mechanism 
leading to tumorigenesis. Sequencing of entire cancer 
genomes has not only begun to provide clues regarding 
functionally relevant mutations, but has also paved the 
way towards understanding the initial exposures leading 
to DNA damage, repair and eventually to mutation 
of specific sequences within a cancer genome. Two 
recent studies of melanoma and small cell lung cancer 
exemplify what type of information can be gained from 
cancer genome sequencing.
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A breakthrough in cancer etiology research has been the 
demonstration  of  exposure­specific  mutational  finger­
prints in the TP53 tumor suppressor gene and in a few 
other genes that are found mutated in human tumors at a 
substantial  frequency  [4,5].  These  studies  of  TP53 
mutations  have  found  UVB­specific  mutations,  C­to­T 
transitions  at  dipyrimidine  sequences  and  CC­to­TT 
tandem  mutations  as  hallmarks  of  sunlight  exposure 
leading to non­melanoma skin cancers [6]. The CC­to­
TT tandem mutations in TP53 are almost never found in 
human tumors not related to sunlight. Similarly, G­to­T 
transversions, which are particularly enriched at methy­
lated CpG (mCpG) dinucleotide sequences in TP53, are 
characteristic  for  smoking­associated  lung  cancers  and 
are much less frequent in lung cancers of non­smokers, 
or  in  other  cancers  not  related  to  smoking  [7].  The 
mCpG­associated G­to­T transversions have been linked 
to one prominent class of cigarette smoke carcinogens, 
the polycyclic aromatic hydrocarbons, which have strong 
selectivity for forming DNA lesions at exactly these DNA 
sequences [8] and for inducing the same type of muta­
tional  events  in  in  vitro  systems.  This  mechanistically 
strengthens the link between smoking and lung cancer [7].
Insights from whole-genome sequencing of human 
cancers
Moving beyond mutational studies of important cancer­
relevant  genes,  such  as  TP53,  it  is  now  possible  to 
conduct high­throughput sequencing of cancer genomes. 
Initial reports focusing on sequencing a large number of 
coding exons have been performed on several types of 
human cancer, including lung cancer [9]. This year, two 
articles  in  Nature  have  expanded  our  knowledge  of 
environmental  carcinogenesis  by  determining  the 
sequence of the entire genomes of a small cell lung cancer 
(SCLC) and a melanoma cell line [10,11].
In  the  first  study,  the  authors  [10]  sequenced  the 
genome  of  a  melanoma  cell  line  using  Illumina  short 
sequence  read  technology.  They  identified  over  30,000 
base substitutions ­ relative to a lymphoblastoid cell line 
from  the  same  patient  ­  and  various  other  events, 
including insertions, deletions, copy number changes and 
rearrangements.  This  study  is  the  first  comprehensive 
analysis  of  a  solid  tumor  genome.  Although  definitive 
novel driver mutations in potential cancer­relevant genes 
were not identified from this single sample, the results 
gave  important  clues  to  the  etiology  and  mechanistic 
history  of  how  the  mutations  have  arisen  as  a  conse­
quence  of  UV­induced  DNA  damage.  By  far  the  most 
common  mutation  was  the  C­to­T  transition  event, 
accounting  for  more  than  two­thirds  of  all  mutations 
(Figure  1).  A  total  of  92%  of  the  C­to­T  mutations 
occurred  at  the  3’  base  of  a  pyrimidine  dinucleotide, 
much higher than expected by chance. These mutations 
are  characteristic  of  UVB­induced  DNA  damage  [12]. 
The frequency of C­to­T and CC­to­TT mutations due to 
sunlight  exposure  is  also  known  to  be  higher  at  CpG 
dinucleotides [12]. C­to­T substitutions (7.7%) and CC­
to­TT double substitutions (10.0%) both showed elevated 
frequencies  at  CpG  dinucleotides  compared  with  that 
expected  by  chance  (4.4%).  Therefore,  the  mutation 
spectrum and sequence context indicate that most C­to­T 
somatic substitutions in the melanoma cell line can be 
attributed to ultraviolet­light­induced DNA damage.
The mutational landscape of this melanoma cell line is 
also  shaped  by  DNA  repair  processes  [10].  Nucleotide 
excision  repair  is  the  repair  pathway  responsible  for 
removing UV­induced pyrimidine dimers. A specialized 
mechanism of transcription­coupled nucleotide excision 
repair  removes  pyrimidine  dimers  preferentially  from 
active genes and specifically from the transcribed strand 
of active genes. This repair activity was reflected in the 
Figure 1. Mutational spectra of a melanoma and a small cell lung 
cancer genome. Data are from [10,11].
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melanoma  genome,  in  which  these  types  of  mutations 
were  more  prominent  on  the  non­transcribed  DNA 
strand of active genes. Genes expressed at a high level 
showed  a  lower  frequency  of  somatic  mutations  than 
genes expressed at a low level, on both the transcribed 
and  non­transcribed  strands.  The  authors  [10]  also 
reported  lower  mutation  prevalence  in  exons  than  in 
introns,  but  this  could  be  due  to  negative  selection  of 
coding sequence mutations.
The second study [11] focused on a SCLC genome. The 
authors [11] used the ABI SoliD sequencing platform to 
generate mate­pair shotgun sequences at more than 30x 
coverage of the tumor genome and a normal B lympho­
cyte  reference  genome  from  the  same  individual.  This 
was the first whole­genome sequence of a human lung 
cancer specimen. Almost 23,000 somatic mutations were 
identified. The enormous statistical power of this dataset, 
not affected by selection, gave an elaborate picture of a 
mutational  landscape  sculpted  by  tobacco  carcinogen 
exposure,  its  sequence  preference  and  several  types  of 
DNA repair pathways. As with other similar studies, the 
fraction of non­synonymous substitutions within protein 
coding  sequences  of  the  cancer  genome  was  not  very 
different from that expected from random events. This 
means  that  many  tumor  genomes  will  need  to  be 
sequenced to identify true tumor­driving mutations. In 
the SCLC genome, obtained from a type of cancer almost 
always associated with tobacco smoking, G­to­T trans­
versions were the most frequent changes observed (34% 
of all mutations; Figure 1). This frequency is remarkably 
similar  to  the  pattern  of  substitutions  observed  in  the 
TP53  tumor  suppressor  gene  in  SCLC  cases  collected 
from the International Agency for Research on Cancer 
TP53 mutation database [7] and suggests the involvement 
of tobacco carcinogens in mutation induction [13]. CpG 
dinucleotides were significantly enriched in the G­to­T 
mutation  set  compared  with  controls.  This,  again,  is 
consistent with the TP53 mutational spectra of smokers’ 
lung cancer. G­to­C transversions were more enriched in 
unmethylated  compartments  of  the  genome  and  were 
often adjacent to A, that is, they occurred in the GpA 
sequence  context.  The  origin  of  such  specific  G­to­C 
mutations is currently unknown but they have also been 
observed in other tumor types [9]. In keeping with what 
is known about G­to­T transversions in TP53 and about 
transcription­coupled and strand­specific repair of bulky 
carcinogen  DNA  adducts,  the  authors  [11]  found  that 
G­to­T transversions were strongly targeted to the non­
transcribed  DNA  strand  of  active  genes.  Significantly 
lower mutation prevalence, on both transcribed and non­
transcribed DNA strands, was observed in more highly 
expressed genes for G­to­T and also for other types of 
mutations,  suggesting  that,  in  addition  to  the 
strand­specific  repair  pathway,  a  repair  pathway  exists 
that preferentially removes lesions from both strands of 
active genes [11].
Recently, Lee et al. [14] analyzed the genome of a lung 
adenocarcinoma  using  high­throughput  sequencing  by 
unchained  combinatorial  probe  anchor  ligation  chem­
istry  on  self­assembling  DNA  nanoarrays.  They  found 
over 50,000 high­confidence single nucleotide variations 
in the tumor relative to normal lung. In this study as in 
the others [10,11], transversions at guanine (G to T) were 
the most common events (46% of all muta  tions), attesting 
to  the  role  of  tobacco  carcinogens  in  shaping  the 
mutational patterns in this tumor.
Conclusions
The  data  presented  in  these  reports  [10,11]  show  the 
power  of  whole­genome  sequencing  to  characterize  at 
unprecedented  levels  of  resolution  and  sequence 
coverage the many complex mutational signatures found 
in human cancers induced by environmental exposures. 
It  is  expected  that  additional  whole­cancer­genome 
sequencing datasets will be forthcoming that will cover 
the  same  tumor  type  (to  address  inter­individual 
variation  or  different  histological  subtypes  of  cancer). 
Other  cancers  for  which  an  environmental  origin  is 
known or suspected ­ for example, aflatoxin­associated 
liver  cancer  ­  will  be  extremely  important  to  analyze. 
Furthermore, it is hoped that whole­genome mutational 
spectra for cancers of unknown etiology ­ for example, 
breast  or  pancreatic  cancer  ­  will  bring  forward  new 
hypotheses  regarding  potential  agents  that  have  com­
patible  mutational  specificity  and  should  further  be 
investigated as causative agents of human cancer.
Abbreviations
GWAS, genome-wide association study; mCpG, methylated CpG; SCLC, small 
cell lung cancer; UV, ultraviolet.
Competing interests
The author declares that he has no competing interests.
Published: 16 August 2010
References
1.  Fletcher O, Houlston RS: Architecture of inherited susceptibility to common 
cancer. Nat Rev Cancer 2010, 10:353-361.
2.  Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, 
Pukkala E, Skytthe A, Hemminki K: Environmental and heritable factors in 
the causation of cancer - analyses of cohorts of twins from Sweden, 
Denmark, and Finland. N Engl J Med 2000, 343:78-85.
3.  Leiter U, Garbe C: Epidemiology of melanoma and nonmelanoma skin 
cancer - the role of sunlight. Adv Exp Med Biol 2008, 624:89-103.
4.  Hainaut P, Hollstein M: p53 and human cancer: the first ten thousand 
mutations. Adv Cancer Res 2000, 77:81-137.
5.  Hussain SP, Harris CC: Molecular epidemiology of human cancer: 
contribution of mutation spectra studies of tumor suppressor genes. 
Cancer Res 1998, 58:4023-4037.
6.  Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, 
Ponten J: A role for sunlight in skin cancer: UV-induced p53 mutations in 
squamous cell carcinoma. Proc Natl Acad Sci USA 1991, 88:10124-10128.
Pfeifer Genome Medicine 2010, 2:54 
http://genomemedicine.com/content/2/8/54
Page 3 of 47.  Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P: 
Tobacco smoke carcinogens, DNA damage and p53 mutations in 
smoking-associated cancers. Oncogene 2002, 21:7435-7451.
8.  Denissenko MF, Pao A, Tang M-s, Pfeifer GP: Preferential formation of 
benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. 
Science 1996, 274:430-432.
9.  Pfeifer GP, Besaratinia A: Mutational spectra of human cancer. Hum Genet 
2009, 125:493-506.
10.  Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, 
Greenman CD, Varela I, Lin ML, Ordonez GR, Bignell GR, Ye K, Alipaz J, Bauer 
MJ, Beare D, Butler A, Carter RJ, Chen L, Cox AJ, Edkins S, Kokko-Gonzales PI, 
Gormley NA, Grocock RJ, Haudenschild CD, Hims MM, James T, Jia M, 
Kingsbury Z, Leroy C, Marshall J, Menzies A, et al.: A comprehensive 
catalogue of somatic mutations from a human cancer genome. Nature 
2010, 463:191-196.
11.  Pleasance ED, Stephens PJ, O’Meara S, McBride DJ, Meynert A, Jones D, Lin 
ML, Beare D, Lau KW, Greenman C, Varela I, Nik-Zainal S, Davies HR, Ordonez 
GR, Mudie LJ, Latimer C, Edkins S, Stebbings L, Chen L, Jia M, Leroy C, Marshall 
J, Menzies A, Butler A, Teague JW, Mangion J, Sun YA, McLaughlin SF, 
Peckham HE, Tsung EF, et al.: A small-cell lung cancer genome with complex 
signatures of tobacco exposure. Nature 2010, 463:184-190.
12.  Pfeifer GP, You YH, Besaratinia A: Mutations induced by ultraviolet light. 
Mutat Res 2005, 571:19-31.
13.  Hecht SS: Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 
1999, 91:1194-1210.
14.  Lee W, Jiang Z, Liu J, Haverty PM, Guan Y, Stinson J, Yue P, Zhang Y, Pant KP, 
Bhatt D, Ha C, Johnson S, Kennemer MI, Mohan S, Nazarenko I, Watanabe C, 
Sparks AB, Shames DS, Gentleman R, de Sauvage FJ, Stern H, Pandita A, 
Ballinger DG, Drmanac R, Modrusan Z, Seshagiri S, Zhang Z: The mutation 
spectrum revealed by paired genome sequences from a lung cancer 
patient. Nature 2010, 465:473-477.
doi:10.1186/gm175
Cite this article as: Pfeifer GP: Environmental exposures and mutational 
patterns of cancer genomes. Genome Medicine 2010, 2:54.
Pfeifer Genome Medicine 2010, 2:54 
http://genomemedicine.com/content/2/8/54
Page 4 of 4